Area of research
Hematology · Public Health, Environmental and Occupational Health
Research interest
Research interests include Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, and Hemoglobinopathies and Related Disorders.
Hematopoietic Stem Cell Transplantation Outcomes for High-Risk AML: A Report From the Children's Oncology Group
Abatacept for acute graft-versus-host disease prophylaxis after unrelated donor hematopoietic cell transplantation
A Phase 3 Randomized Trial for Patients with De Novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO - a Report from the Children's Oncology Group
Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure.
Higher abatacept exposure after transplant decreases acute GVHD risk without increasing adverse events
Hematopoietic Cell Transplantation in the Treatment of Pediatric Acute Myelogenous Leukemia and Myelodysplastic Syndromes: Guidelines from the American Society of Transplantation and Cellular Therapy
Long-Term Organ Function After HCT for SCD: A Report From the Sickle Cell Transplant Advocacy and Research Alliance
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD
Spatiotemporal single-cell profiling reveals that invasive and tissue-resident memory donor CD8 <sup>+</sup> T cells drive gastrointestinal acute graft-versus-host disease
Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation
Mixed‐phenotype acute leukemia: A cohort and consensus research strategy from the Children’s Oncology Group Acute Leukemia of Ambiguous Lineage Task Force
The genetic basis and cell of origin of mixed phenotype acute leukaemia
Treatment strategies for adolescent and young adult patients with acute myeloid leukemia
Influence of Age on Acute and Chronic GVHD in Children Undergoing HLA-Identical Sibling Bone Marrow Transplantation for Acute Leukemia: Implications for Prophylaxis
Haematopoietic stem cell transplantation for sickle cell disease – current practice and new approaches
CMV reactivation drives posttransplant T-cell reconstitution and results in defects in the underlying TCRβ repertoire
Immunophenotypic parameters and <scp>RBC</scp> alloimmunization in children with sickle cell disease on chronic transfusion
Immune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapy
Red blood cell transfusions are associated with <scp>HLA</scp> class I but not H‐Y alloantibodies in children with sickle cell disease
Renal Transplantation Using Belatacept Without Maintenance Steroids or Calcineurin Inhibitors
Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens
In Vivo T Cell Costimulation Blockade with Abatacept for Acute Graft-versus-Host Disease Prevention: A First-in-Disease Trial
Differences in outcomes of newly diagnosed acute myeloid leukemia for adolescent/young adult and younger patients
The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors
Outcome of adolescents and young adults with acute myeloid leukemia treated on COG trials compared to CALGB and SWOG trials
Comparable survival for pediatric acute myeloid leukemia with poor-risk cytogenetics following chemotherapy, matched related donor, or unrelated donor transplantation
Evaluation of HLA matching in unrelated hematopoietic stem cell transplantation for nonmalignant disorders